Castro, C. d., Hillmen, P., Szer, J., Weitz, I., Röth, A., Hoechsmann, B., . . . Latour, R. P. d. (2020). Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood, 136, 35-37. https://doi.org/10.1016/s2152-2650(20)30783-7
Citace podle Chicago (17th ed.)Castro, Carlos de, et al. "Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria." Blood 136 (2020): 35-37. https://doi.org/10.1016/s2152-2650(20)30783-7.
Citace podle MLA (9th ed.)Castro, Carlos de, et al. "Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria." Blood, vol. 136, 2020, pp. 35-37, https://doi.org/10.1016/s2152-2650(20)30783-7.